Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With DexcomBusiness Wire • 03/25/25
Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does NextThe Motley Fool • 03/19/25
Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 CareBusiness Wire • 03/19/25
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't WorriedInvestors Business Daily • 03/10/25
DexCom, Inc. (DXCM) Presents at 46th Annual Raymond James Institutional Investors Brokers Conference (Transcript)Seeking Alpha • 03/04/25